Rapid genotype method to distinguish frequent and/or functional polymorphisms in human N-acetyltransferase-1

被引：34

作者：

Doll, MA ^{[1
]}

Hein, DW ^{[1
]}

机构：

[1] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA

来源：

ANALYTICAL BIOCHEMISTRY | 2002年 / 301卷 / 02期

关键词：

D O I：

10.1006/abio.2001.5520

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：328 / 332

页数：5

共 22 条

[1]

BELL DA, 1995, CANCER RES, V55, P5226

[2]

BRUHN C, 1999, BIOCHEM PHARMACOL, V58, P5226

[3] Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations [J].

Butcher, NJ ;

Ilett, KF ;

Minchin, RF .

PHARMACOGENETICS, 1998, 8 (01) :67-72

[4]

Cascorbi I, 2001, CANCER RES, V61, P5051

[5] Characterization of naturally occurring and recombinant human N-acetyltransferase variants encoded by NAT1 [J].

de León, JH ;

Vatsis, KP ;

Weber, WW .

MOLECULAR PHARMACOLOGY, 2000, 58 (02) :288-299

[6] Identification of a novel allele at the human NAT1 acetyltransferase locus [J].

Doll, MA ;

Jiang, W ;

Deitz, AC ;

Rustan, TD ;

Hein, DW .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (03) :584-591

[7] Comprehensive human NAT2 genotype method using single nucleotide polymorphism-specific polymerase chain reaction primers and fluorogenic probes [J].

Doll, MA ;

Hein, DW .

ANALYTICAL BIOCHEMISTRY, 2001, 288 (01) :106-108

[8] Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1 [J].

Fretland, AJ ;

Doll, MA ;

Leff, MA ;

Hein, DW .

PHARMACOGENETICS, 2001, 11 (06) :511-520

[9] METABOLIC-ACTIVATION AND DEACTIVATION OF ARYLAMINE CARCINOGENS BY RECOMBINANT HUMAN NAT1 AND POLYMORPHIC NAT2 ACETYLTRANSFERASES [J].

HEIN, DW ;

DOLL, MA ;

RUSTAN, TD ;

GRAY, K ;

FENG, Y ;

FERGUSON, RJ ;

GRANT, DM .

CARCINOGENESIS, 1993, 14 (08) :1633-1638

[10]

Hein DW, 2000, CANCER EPIDEM BIOMAR, V9, P29

← 1 2 3 →